Literature DB >> 15818400

Carcinogenesis, cancer therapy and chemoprevention.

M V Blagosklonny1.   

Abstract

Carcinogenesis and cancer therapy are two sides of the same coin, such that the same cytotoxic agent can cause cancer and be used to treat cancer. This review links carcinogenesis, chemoprevention and cancer therapy in one process driven by cytotoxic agents (carcinoagents) that select either for or against cells with oncogenic alterations. By unifying therapy and cancer promotion and by distinguishing nononcogenic and oncogenic mechanisms of resistance, I discuss anticancer- and chemopreventive agent-induced carcinogenesis and tumor progression and, vice versa, carcinogens as anticancer drugs, anticancer drugs as chemopreventive agents and exploiting oncogene-addiction and drug resistance for chemoprevention and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818400     DOI: 10.1038/sj.cdd.4401610

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  36 in total

Review 1.  Rapalogs in cancer prevention: anti-aging or anticancer?

Authors:  Mikhail V Blagosklonny
Journal:  Cancer Biol Ther       Date:  2012-11-14       Impact factor: 4.742

2.  Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.

Authors:  Yves-Paul Vandewynckel; Debby Laukens; Lindsey Devisscher; Annelies Paridaens; Eliene Bogaerts; Xavier Verhelst; Anja Van den Bussche; Sarah Raevens; Christophe Van Steenkiste; Marleen Van Troys; Christophe Ampe; Benedicte Descamps; Chris Vanhove; Olivier Govaere; Anja Geerts; Hans Van Vlierberghe
Journal:  Oncotarget       Date:  2015-09-29

3.  Association of benign prostatic hyperplasia and subsequent risk of bladder cancer: an Asian population cohort study.

Authors:  Chu-Wen Fang; Cheng-Hsi Liao; Shih-Chi Wu; Chih-Hsin Muo
Journal:  World J Urol       Date:  2018-02-09       Impact factor: 4.226

4.  Impaired DNA replication within progenitor cell pools promotes leukemogenesis.

Authors:  Ganna Bilousova; Andriy Marusyk; Christopher C Porter; Robert D Cardiff; James DeGregori
Journal:  PLoS Biol       Date:  2005-11-15       Impact factor: 8.029

5.  Flavonoids from Chinese bayberry leaves induced apoptosis and G1 cell cycle arrest via Erk pathway in ovarian cancer cells.

Authors:  Yu Zhang; Shiguo Chen; Chaoyang Wei; Gary O Rankin; Xingqian Ye; Yi Charlie Chen
Journal:  Eur J Med Chem       Date:  2018-01-31       Impact factor: 6.514

Review 6.  Declining cellular fitness with age promotes cancer initiation by selecting for adaptive oncogenic mutations.

Authors:  Andriy Marusyk; James DeGregori
Journal:  Biochim Biophys Acta       Date:  2007-10-12

Review 7.  Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities.

Authors:  Jessica Plati; Octavian Bucur; Roya Khosravi-Far
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

8.  Irradiation selects for p53-deficient hematopoietic progenitors.

Authors:  Andriy Marusyk; Christopher C Porter; Vadym Zaberezhnyy; James DeGregori
Journal:  PLoS Biol       Date:  2010-03-02       Impact factor: 8.029

9.  Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene.

Authors:  Yanlin Yu; Pingyao Zeng; Jingbo Xiong; Ziyang Liu; Shelley L Berger; Glenn Merlino
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

10.  Replicational stress selects for p53 mutation.

Authors:  Andriy Marusyk; James DeGregori
Journal:  Cell Cycle       Date:  2007-07-10       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.